Ali Abbara
London, United Kingdom
Tue 12 14:45
OC6.1
Oral Communications 6 - Reproductive Endocrinology and Biology
Effect of MVT-602, a potent kisspeptin receptor agonist, on LH levels in healthy pre-menopausal women undergoing a minimal controlled ovarian stimulation protocol
London, United Kingdom
John Achermann
London, United Kingdom
Tue 12 12:40
MTE3
Meet The Expert 3
Update on DSD genetics
London, United Kingdom
Elina Akalestou
London, United Kingdom
Mon 11 16:20
OC1.6
Oral Communications 1 - Metabolism and Obesity
Metabolic surgery reduces kidney SGLT2 expression in mice
London, United Kingdom
Haya Alessimii
London, United Kingdom
Tue 12 13:45
OP3.3
Oral Posters 3 - Metabolism and Obesity
The Impact of Subcutaneous Infusions of three Anorexigenic Gut Hormones Glucagon-like Peptide-1, Oxyntomodulin and Peptide YY (GOP) on the Psychological Health of Obese Diabetic Patients.
London, United Kingdom
Sarah Ali
London, United Kingdom
Mon 11 11:35
HDI1.3
How do I…1
How do I decide which patients with gynaecomastia need more detailed evaluation?
London, United Kingdom
Aldara Alonso
London, United Kingdom
Mon 11 15:50
OC2.4
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression
London, United Kingdom
Mohammed Alshahrani
Birmingham, United Kingdom
Mon 11 13:40
OP2.4
Oral Posters 2 - Thyroid
The proto-oncogene PBF mediates Src modulation of radioiodine uptake
Birmingham, United Kingdom
Francesco Argenton
Padua, Italy
Mon 11 11:05
BPW1.1
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In vivo models of endocrinology: new zebrafish models
Padua, Italy
Anastasia Arvaniti
Oxford, United Kingdom
Tue 12 13:40
OP3.2
Oral Posters 3 - Metabolism and Obesity
Intestinal injury and evidence of increased gut permeability in female AKR1D1 knockout mice
Oxford, United Kingdom
M. Babu
(Cambridge, United Kingdom)
Mon 11 17:35
IN2.2
Innovation Session 2: Big data in space and time
Data Science Approaches to GPCRs and Nuclear Receptors
(Cambridge, United Kingdom)
Steve Ball
Manchester, United Kingdom
Mon 11 11:05
CMW1.1
Clinical Management Workshop 1: Salt & Water
Management of hyponatraemia
Manchester, United Kingdom
Sean Bankier
Edinburgh, United Kingdom
Tue 12 15:15
OC5.3
Oral Communications 5 - Adrenal and Cardiovascular
Common variants in the gene encoding corticosteroid binding globulin influence cortisol-responsive gene networks in human adipose tissue
Edinburgh, United Kingdom
Waiel Bashari
Cambridge, United Kingdom
Wed 13 13:55
OC6.1
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease
Cambridge, United Kingdom
Laurent Beck
Nantes, France
Tue 12 11:35
S3.2
Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
Phosphate Sensing
Nantes, France
Clemens Bergwitz
New Haven, USA)
Tue 12 11:05
S3.1
Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
Advances in FGF23 Signalling
New Haven, USA)
Jérôme Bertherat
Paris, France
Wed 13 09:00
PL8
Plenary 8: CET Visiting Professor Lecture
Cushing’s syndrome as a model of endocrine tumorigenesis
Paris, France
Felix Beuschlein
Zürich, Switzerland
Tue 12 18:20
PL6
Plenary 6: Society for Endocrinology European Medal Lecture
Mechanisms and consequences of endocrine autonomy – lessons learned from the adrenal cortex
Zürich, Switzerland
Antonio Bianco
Chicago, USA
Wed 13 10:50
S4.1
Symposium 4: Thyroid hormone a key regulator in inflammation?
Thyroid hormone inhibits lung fibrosis 
Chicago, USA
Professor Kristien Boelaert
Birmingham, UK
Mon 11 11:20
HDI1.2
How do I…1
How do I manage an incidental finding of a thyroid nodule
Birmingham, UK
Mark Bollington
London, United Kingdom
Wed 13 14:00
OC6.2
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Transcriptomic analyses reveal deregulation of focal adhesion pathway in Aip KO mice and AIP mutation positive human tumours
London, United Kingdom
Barbara Boucher
London, United Kingdom
Tue 12 17:45
SE1.3
Senior Endocrinologists' Session
Potential benefits of better vitamin D status for non-bony disorders?
London, United Kingdom
Chas Bountra
Oxford, United Kingdom
Wed 13 12:25
MTE5
Meet The Expert 5
Novel Epigenetic inhibitors
Oxford, United Kingdom
Luke Boyle
Edinburgh, United Kingdom
Tue 12 15:00
OC5.2
Oral Communications 5 - Adrenal and Cardiovascular
Subclinical alpha-1 antitrypsin deficiency is associated with increased free cortisol fraction in plasma
Edinburgh, United Kingdom
Dr Antonia Brooke
Exeter, UK
Tue 12 11:35
NS1.2
Nurses' session 1: NICE & T3
The health care professional & patient consultation - Informed decision making
Exeter, UK
Wed 13 15:55
ROE1.3
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
SfE Interdepartmental peer review
Exeter, UK
Aleksandra Buha
Belgrade, Serbia
Tue 12 15:15
OC4.3
Oral Communications 4 - Thyroid
The disturbed thyroid gland homeostasis in conditions of subacute exposure to thyroid-disrupting chemicals: experimental study in Wistar rats
Belgrade, Serbia
Dr Inês Cebola
London, United Kingdom
Tue 12 09:35
EC1.1
Early Careers and Plenary Orals
Early Career Prize lecture Basic Science
London, United Kingdom
Andrew Childs
London, United Kingdom
Wed 13 09:35
SK2.1
Basic Skills: Introduction to teaching
Getting started in undergraduate teaching; what, when and how?
London, United Kingdom
Zhuo Chong
Glasgow, United Kingdom
Mon 11 15:20
OC3.2
Oral Communications 3 - Bone and Calcium
Hypophosphatasia in adulthood - are patients really “unaffected”
Glasgow, United Kingdom
Vasileios Chortis
Birmingham, United Kingdom
Wed 13 14:10
OP6.4
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection
Birmingham, United Kingdom
Professor Mirjam Christ-Crain
Basel, Switzerland
Mon 11 12:05
CMW1.3
Clinical Management Workshop 1: Salt & Water
Co-peptin- a new player in the diagnosis of salt and water balance
Basel, Switzerland
Jeremy Cobbold
Oxford, United Kingdom
Wed 13 12:25
MTE4.1
Meet The Expert 4
Fighting liver fat
Oxford, United Kingdom
Martine Cohen-Solal
Paris, France
Mon 11 17:45
IN1.3
Innovation Session 1: Advances in understanding skeletal disease
Bone fragility in patients with chronic kidney diseases
Paris, France
Timothy Cole
Melbourne, Australia
Mon 11 12:50
OP1.1
Oral Posters 1 - Adrenal and Cardiovascular
Betamethasone/GR ChIP-Seq analysis defines a discrete set of canonical GR homodimer binding sites in primary fetal rat lung mesenchymal fibroblasts
Melbourne, Australia
Roger Cone
Ann Arbor, USA
Tue 12 09:00
PL5
Plenary 5: Society for Endocrinology International Medal Lecture
The Melanocortin Microcircuitry and its Role in Energy Homeostasis
Ann Arbor, USA
Dr Rachel Crowley
Dublin, Ireland
Tue 12 18:00
HDI2.6
How do I…2
How do I manage withdrawal of denosumab
Dublin, Ireland
Liz Crowne
Bristol, United Kingdom
Tue 12 17:15
HDI2.3
How do I…2
When and how should I start screening for MEN1 in children
Bristol, United Kingdom
Federica Cuozzo
Birmingham, United Kingdom
Mon 11 16:05
OC1.5
Oral Communications 1 - Metabolism and Obesity
Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress
Birmingham, United Kingdom
Julian Davis
Manchester, United Kingdom
Wed 13 17:30
PL10
Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Pituitary cells alive: hormone genes pulsing on and off
Manchester, United Kingdom
Harshal Deshmukh
Hull, United Kingdom
Tue 12 14:20
OP4.3
Oral Posters 4 - Bone and Calcium
Mendelian randomization and machine learning to assess the causal association of Type 2 Diabetes with osteoporosis and fragility fractures
Hull, United Kingdom
Waljit Dhillo
London, UK
Mon 11 17:05
IN3.1
Innovation Session 3: NIHR Pathways to clinical impact
From basic science to life changing therapies
London, UK
Rima Dhillon-Smith
Birmingham, United Kingdom
Tue 12 15:45
OC4.5
Oral Communications 4 - Thyroid
The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom
Birmingham, United Kingdom
Professor Maralyn Druce
London, UK
Tue 12 16:45
ECS1.1
Early Careers Symposium: Engaging with the public
How your Society can help you engage the public
London, UK
Professor Colin Duncan
Edinburgh, UK
Tue 12 11:35
S2.2
Symposium 2: New insights into PCOS
PCOS, obesity and energy balance
Edinburgh, UK
James Fagin
New York, USA)
Wed 13 08:30
PL7
Plenary 7: British Thyroid Association Pitt-Rivers Lecture
Thyroid cancer genomics, differentiation state and response to radioiodine
New York, USA)
Professor Sadaf Farooqi
Cambridge, UK
Mon 11 18:40
D1.2
Debate: Nature vs Nurture
FOR - This house believes nature not nurture determines our bodyweight
Cambridge, UK
Andrea Frilling
London, United Kingdom
Wed 13 11:20
S6.2
Symposium 6: New horizons in neuro-endocrine disease
Using genetics to inform on pharmalogical targeting of NETs
London, United Kingdom
Seiji Fukumoto
Tokushima, Japan
Tue 12 12:05
S3.3
Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
Tokushima, Japan
Kathryn Garner
Newcastle-Upon-Tyne, United Kingdom
Wed 13 16:15
BPW2.3
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
High content imaging for monitoring signalling dynamics in single cells
Newcastle-Upon-Tyne, United Kingdom
Stella George
Stevenage, United Kingdom
Wed 13 16:15
ROE1.4
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
The 2018 diabetes and endocrinology consultant workforce survey (SfE/ABCD/DUK)
Stevenage, United Kingdom
Douglas Gibson
Edinburgh, United Kingdom
Wed 13 13:25
OP5.2
Oral Posters 5 - Reproductive Endocrinology and Biology
Profiling the expression and function of the truncated oestrogen receptor isoform ER46 in human endometrium
Edinburgh, United Kingdom
Robert Gifford
Edinburgh, United Kingdom
Wed 13 13:20
OP5.1
Oral Posters 5 - Reproductive Endocrinology and Biology
Hypothalamic-pituitary-gonadal (HPG) axis suppression during basic military training in women despite increased adiposity and insulin resistance
Edinburgh, United Kingdom
Professor Neil Gittoes
Birmingham, United Kingdom
Tue 12 15:15
NS2.2
Nurses' session 2: Management of Hyper & Hypocalcaemia
Patient management of hypercalcaemia & when should the surgeon intervene?
Birmingham, United Kingdom
Wed 13 15:15
ROE1.1
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
National standards and the specialised endocrinology Clinical Reference Group
Birmingham, United Kingdom
Wed 13 16:15
CMW2.3
Clinical Management Workshop 2: Hyperparathyroidism
Challenges in recurrent hyperparathyroidism
Birmingham, United Kingdom
Michelle Goldsworthy
Oxford, UK
Mon 11 16:20
OC3.6
Oral Communications 3 - Bone and Calcium
The role of biased calcium-sensing receptor signalling in urinary calcium excretion and kidney stone disease
Oxford, UK
Emily Goodchild
London, United Kingdom
Tue 12 16:00
OC5.6
Oral Communications 5 - Adrenal and Cardiovascular
SLC35F1, a potential marker for aldosterone producing cell clusters
London, United Kingdom
Dr. Caroline Gorvin
Birmingham, UK
Mon 11 10:20
WIN1
What Is New
What is New in Basic Endocrinology Research
Birmingham, UK
Fiona Gribble
Cambridge, United Kingdom
Tue 12 11:05
S1.1
Symposium 1: Gut hormones physiology pathology and pharamcology
Physiology and pharmacology of gut hormones
Cambridge, United Kingdom
Simona Grozinsky-Glasberg
Hadassah, Israel
Wed 13 10:50
S6.1
Symposium 6: New horizons in neuro-endocrine disease
Preclinical drug studies for MEN1 NETs
Hadassah, Israel
Angelica Gualtieri
London, United Kingdom
Mon 11 16:05
OC2.5
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Efnb2 controls pituitary gland development by regulating proliferation of the pituitary stem/progenitor cells and EMT within the pituitary stem cell niche.
London, United Kingdom
Professor Mark Gurnell 
Cambridge, UK
Tue 12 12:40
MTE2
Meet The Expert 2
When should I consider functional imaging in adrenocortical disease?

Unknown speaker

Cambridge, UK
Wed 13 11:50
S6.3
Symposium 6: New horizons in neuro-endocrine disease
Molecular endocrine imaging in occult de novo or recurrent pituitary disease

Unknown speaker

Cambridge, UK
Professor Fadil Hannan
Oxford, United Kingdom
Tue 12 10:25
EC1.4
Early Careers and Plenary Orals
CET Best Abstract Basic
Oxford, United Kingdom
Mark Hannon
Bantry, Ireland
Mon 11 11:35
CMW1.2
Clinical Management Workshop 1: Salt & Water
Diabetes Insipidus - management challenges and pitfalls
Bantry, Ireland
Aylin Hanyaloglu
London, United Kingdom
Wed 13 15:45
BPW2.2
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
Spatial programming of GPCR signalling
London, United Kingdom
Ultan Healy
Oxford, United Kingdom
Mon 11 16:05
OC3.5
Oral Communications 3 - Bone and Calcium
Mutational analysis of a patient with familial hypocalciuric hypercalcaemia identifies a novel p.Ser182Cys mutation, which is predicted to disrupt the calcium sensing receptor (CaSR) extracellular domain
Oxford, United Kingdom
Dr Claire Higham
Manchester, UK
Tue 12 17:45
HDI2.5
How do I…2
How do I… manage therapeutic glucocorticoid withdrawal

Unknown speaker

Manchester, UK
Catriona Hilton
Oxford, United Kingdom
Tue 12 14:25
OP4.4
Oral Posters 4 - Bone and Calcium
The associations between body fat distribution and bone mineral density in the Oxford Biobank: a cross sectional study
Oxford, United Kingdom
Professor Leanne Hodson
Oxford, UK
Mon 11 15:20
OC1.2
Oral Communications 1 - Metabolism and Obesity
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
Oxford, UK
Dr Shazia Hussain
London, UK
Mon 11 13:25
OP2.1
Oral Posters 2 - Thyroid
Day case radioiodine for remnant ablation in differentiated thyroid cancer patients is safe and helps reduce bed pressures in a busy tertiary centre hospital
London, UK
Bolanle Iranloye
Lagos, Nigeria
Wed 13 13:30
OP5.3
Oral Posters 5 - Reproductive Endocrinology and Biology
Stress is implicated in programming metabolic disorders in the offspring of fructose-induced diabetic rats
Lagos, Nigeria
Mohammad Jeeyavudeen
Aberdeen, United Kingdom
Tue 12 15:00
OC4.2
Oral Communications 4 - Thyroid
Reduced Length of Hospital Stay with the use of recombinant TSH compared to Thyroid Hormone Withdrawal –A two centre retrospective study
Aberdeen, United Kingdom
Dr Gillian Johnson
London, UK
Tue 12 15:00
OC6.2
Oral Communications 6 - Reproductive Endocrinology and Biology
Differential follicle stimulating hormone glycosylation modulates follicle growth and survival rates
London, UK
Chris Jones
Leeds, United Kingdom
Tue 12 17:03
ECS1.2
Early Careers Symposium: Engaging with the public
Making the best of what you’re given – public engagement grants
Leeds, United Kingdom
Niki Karavitaki
Birmingham, UK
Tue 12 17:30
HDI2.4
How do I…2
How do I decide when to initiate dopamine agonist withdrawal
Birmingham, UK
Soo Kim
London, United Kingdom
Tue 12 15:30
OC6.4
Oral Communications 6 - Reproductive Endocrinology and Biology
Kallmann syndrome-associated WDR11 regulates primordial germ cell development
London, United Kingdom
Kreepa Kooblall
Oxford, UK
Mon 11 15:05
OC3.1
Oral Communications 3 - Bone and Calcium
A mouse model generated by CRISPR-Cas9 with a frameshift mutation in the nuclear factor 1/X (NFIX) gene has phenotypic features reported in Marshall-Smith Syndrome (MSS) patients
Oxford, UK
Professor Márta Korbonits
London, UK
Mon 11 17:45
IN3.3
Innovation Session 3: NIHR Pathways to clinical impact
Championing Rare Disease Research

Unknown speaker

London, UK
Andrew Lansdown
Cardiff, United Kingdom
Wed 13 10:05
SK1.3
Clincal Skills: Being a consultant - How to get the job and keep it
How do I set up a new service?
Cardiff, United Kingdom
Fiona Leslie
Leeds, United Kingdom
Mon 11 13:05
OP1.4
Oral Posters 1 - Adrenal and Cardiovascular
Global phosphoproteomics links rapidly induced cytoplasmic signals to transcriptional control
Leeds, United Kingdom
Dr Kate Lines
Oxford, UK
Mon 11 15:50
OC3.4
Oral Communications 3 - Bone and Calcium
Characterisation of rare GNA11 variants reveals 8 novel residues important for signalling by the calcium-sensing receptor: Relevance for FHH and ADH
Oxford, UK
Tue 12 13:50
OP3.4
Oral Posters 3 - Metabolism and Obesity
Mice with a gain-of function Gα11 mutation have autosomal dominant hypocalcaemia, but not impaired glucose metabolism.
Oxford, UK
Kate Lines
Oxford, United Kingdom
Wed 13 14:05
OP6.3
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
JQ1 treatment significantly reduces POMC expression and ACTH secretion from the corticotrophinoma cell line, AtT20
Oxford, United Kingdom
Outi Mäkitie
Helsinki, Finland
Mon 11 17:05
IN1.1
Innovation Session 1: Advances in understanding skeletal disease
Identifying new skeletal disease
Helsinki, Finland
Ms. Anne Marland
Oxford, UK
Tue 12 17:39
ECS1.4
Early Careers Symposium: Engaging with the public
Meaningful engagement with patients: The importance of recognising common humanity in patients is key to improving relationships’
Oxford, UK
Claire Martin
Birmingham, United Kingdom
Tue 12 15:30
OC5.4
Oral Communications 5 - Adrenal and Cardiovascular
Pre-receptor metabolism and signalling of glucocorticoids between macrophages and fibroblasts
Birmingham, United Kingdom
Dr. Christine May
Oxford, UK
Wed 13 09:35
SK1.1
Clincal Skills: Being a consultant - How to get the job and keep it
How to get the consultant post you want
Oxford, UK
Anisha Mistry
London, UK
Mon 11 15:20
OC2.2
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Investigating the role of AIP in pituitary tumourigenesis
London, UK
Alice Mitchell
London, United Kingdom
Tue 12 13:35
OP3.1
Oral Posters 3 - Metabolism and Obesity
Intermittent cold exposure ameliorates fatty liver disease
London, United Kingdom
Patrice Mollard
Montpellier, France
Wed 13 15:15
BPW2.1
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
In vivo imaging of endocrine cell networks
Montpellier, France
Dr Carla Moran
Dublin, Ireland
Tue 12 12:40
MTE1
Meet The Expert 1
Thyroid disease after immune reconstitution
Dublin, Ireland
Jean Munday
Portsmouth, United Kingdom
Tue 12 12:05
NS1.3
Nurses' session 1: NICE & T3
A Beginners Guide: setting up a Nurse-Led Thyroid Clinic
Portsmouth, United Kingdom
Professor Kevin Murphy
London, United Kingdom
Wed 13 09:57
SK2.2
Basic Skills: Introduction to teaching
Challenging students and difficult supervisors; how to supervise students effectively when things go wrong. 
London, United Kingdom
Professor John Newell-Price
Sheffield, UK
Mon 11 10:35
WIN2
What Is New
What is New in Clinical Endocrinology Research
Sheffield, UK
Tue 12 16:45
HDI2.1
How do I…2
How do I diagnose cyclical Cushing's
Sheffield, UK
Hannah Nieto
Birmingham, United Kingdom
Tue 12 16:00
OC4.6
Oral Communications 4 - Thyroid
Driver events in thyroid cancer recurrence
Birmingham, United Kingdom
Nikolaos Nikolaou
Oxford, United Kingdom
Mon 11 15:50
OC1.4
Oral Communications 1 - Metabolism and Obesity
5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.
Oxford, United Kingdom
Henrik Oster
Lübeck, Germany
Wed 13 10:50
S5.1
Symposium 5: Stress – The rhythm of life
The interplay between stress, biological clocks and metabolic function
Lübeck, Germany
Kanapath Oungpasuk
London, United Kingdom
Tue 12 14:10
OP4.1
Oral Posters 4 - Bone and Calcium
Oral calcium loading test can predict the progression of hypercalcaemic primary hyperparathyroidism in patients with normocalcaemic hyperparathyroidism
London, United Kingdom
Soo-Mi Park
Cambridge, United Kingdom
Wed 13 15:45
CMW2.2
Clinical Management Workshop 2: Hyperparathyroidism
Genetic testing in hyperparathyroidism across the ages- who to test and why
Cambridge, United Kingdom
Malcolm Peaker
Ayr, United Kingdom
Tue 12 16:45
SE1.1
Senior Endocrinologists' Session
What happened to the adrenal X-zone?
Ayr, United Kingdom
Maria Phylactou
London, United Kingdom
Wed 13 13:35
OP5.4
Oral Posters 5 - Reproductive Endocrinology and Biology
Kisspeptin as a novel biomarker for pregnancy complications
London, United Kingdom
Terhi Piltonen
Oulu, Finland
Tue 12 12:05
S2.3
Symposium 2: New insights into PCOS
Origins of obesity in women with PCOS
Oulu, Finland
Robert Pope
Bristol Medical School, United Kingdom
Mon 11 15:35
OC2.3
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
ErbB receptor signalling in MCF7 breast cancer cells: an information theoretic approach
Bristol Medical School, United Kingdom
Dr Alessandro Prete
Birmingham, UK
Tue 12 10:15
EC1.3
Early Careers and Plenary Orals
Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess
Birmingham, UK
Markus Ralser
London, United Kingdom
Mon 11 14:30
PL2
Plenary 2: Society for Endocrinology Starling Medal Lecture
From its origins to the modern metabolic network
London, United Kingdom
Dr Martin Read
Birmingham, UK
Tue 12 14:45
OC4.1
Oral Communications 4 - Thyroid
A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy
Birmingham, UK
Professor Aled Rees
Cardiff, United Kingdom
Mon 11 11:50
HDI1.4
How do I…1
How do I manage hair loss and hair growth in PCOS?
Cardiff, United Kingdom
Rebecca Reynolds
Edinburgh, United Kingdom
Wed 13 15:15
CMW2.1
Clinical Management Workshop 2: Hyperparathyroidism
Management of primary hyperparathyroidism in pregnancy
Edinburgh, United Kingdom
Karine Rizzoti
London, UK
Mon 11 17:05
IN2.1
Innovation Session 2: Big data in space and time
Single cell RNA-seq of endocrine organs
London, UK
Hussam Rostom
Oxford, United Kingdom
Mon 11 16:20
OC2.6
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Post-operative copeptin analysis as a predictor of diabetes insipidus after pituitary surgery
Oxford, United Kingdom
Georgina Russell
Bristol, United Kingdom
Mon 11 15:05
OC2.1
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Differential effects of subcutaneous pulsatile versus oral hydrocortisone replacement therapy on fMRI resting state and task based emotional processing in Patients with Primary Adrenal insufficiency
Bristol, United Kingdom
Sophia Sakka
London, United Kingdom
Mon 11 11:05
HDI1.1
How do I…1
Management of osteoporosis in children and adolescents
London, United Kingdom
Richard Santen
Virginia, USA
Tue 12 17:15
SE1.2
Senior Endocrinologists' Session
Is the estrogenic component of Premarin all bad?
Virginia, USA
Philippa Saunders
Edinburgh, United Kingdom
Wed 13 16:50
PL9
Plenary 9: Society for Endocrinology Medal Lecture
Sex steroids and the endometrium: dynamics and disorders
Edinburgh, United Kingdom
Tom Scanlan
Oregon Health & Science University, USA
Wed 13 11:50
S4.3
Symposium 4: Thyroid hormone a key regulator in inflammation?
TED novel agents how they work and how to use them CIRTED MINGO papers
Oregon Health & Science University, USA
Lina Schiffer
Birmingham, United Kingdom
Mon 11 15:05
OC1.1
Oral Communications 1 - Metabolism and Obesity
Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue
Birmingham, United Kingdom
Russell Senanayake
Cambridge, UK
Mon 11 13:00
OP1.3
Oral Posters 1 - Adrenal and Cardiovascular
Combining 11C-Metomidate PET/CT and 18F-FDG PET/CT – a new approach to phenotyping indeterminate adrenal lesions
Cambridge, UK
Dr Helen Simpson
London, UK
Tue 12 17:21
ECS1.3
Early Careers Symposium: Engaging with the public
How to reach out across social media
London, UK
Georgina Sneddon
Newcastle upon Tyne, United Kingdom
Mon 11 13:30
OP2.2
Oral Posters 2 - Thyroid
The SH2B3 tryptophan 262 variant is associated with Graves’ disease and Addison’s disease
Newcastle upon Tyne, United Kingdom
Lina Sorour
Sheffield, United Kingdom
Mon 11 15:35
OC3.3
Oral Communications 3 - Bone and Calcium
Generation of a long acting parathyroid hormone hybrid analogue through fusion to a binding protein
Sheffield, United Kingdom
Alina Sovetkina
London, United Kingdom
Tue 12 15:30
OC4.4
Oral Communications 4 - Thyroid
Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment
London, United Kingdom
Anne Spek
Amsterdam, The Netherlands
Wed 13 11:20
S4.2
Symposium 4: Thyroid hormone a key regulator in inflammation?
Thyroid hormone regulation of Inflammation 
Amsterdam, The Netherlands
Francesca Spiga
Bristol, United Kingdom
Wed 13 11:20
S5.2
Symposium 5: Stress – The rhythm of life
Dynamic of Adrenal in health and disease
Bristol, United Kingdom
Umasuthan Srirangalingam
London, United Kingdom
Mon 11 12:05
HDI1.5
How do I…1
How do I induce spermatogenesis?
London, United Kingdom
Constantine Stratakis
Greece
Mon 11 18:10
PL3
Plenary 3: Society for Endocrinology Dale Medal Lecture
From Carney complex to gigantism and Cushing disease: an insight in the genetics of pituitary tumors
Greece
Dr Abd Tahrani
Birmingham, UK
Mon 11 12:20
HDI1.6
How do I…1
How do I choose between weight loss interventions?
Birmingham, UK
Wed 13 11:50
S5.3
Symposium 5: Stress – The rhythm of life
The interplay between sleep and the endocrine system
Birmingham, UK
Prof Tricia Tan
London, United Kingdom
Tue 12 11:35
S1.2
Symposium 1: Gut hormones physiology pathology and pharamcology
Combination of gut hormone therapy
London, United Kingdom
Professor Peter Taylor
Cardiff, UK
Tue 12 17:00
HDI2.2
How do I…2
How should I manage non-standard thyroid hormone replacement
Cardiff, UK
Dr Tiganescu
Leeds, United Kingdom)
Tue 12 09:55
EC1.2
Early Careers and Plenary Orals
Early Career Prize lecture Translational
Leeds, United Kingdom)
Kate Timms
Leeds, United Kingdom
Tue 12 15:15
OC6.3
Oral Communications 6 - Reproductive Endocrinology and Biology
Investigating the impact of altered maternal extracellular vesicle miRNAs on placental function in women with gestational diabetes complicated by large for gestational age infants
Leeds, United Kingdom
Julia Toews
Vancouver, Canada
Tue 12 14:45
OC5.1
Oral Communications 5 - Adrenal and Cardiovascular
Central role for corticosteroid-binding globulin in rat HPA axis sexual dimorphism
Vancouver, Canada
Professor Jeremy Tomlinson
Oxford, UK
Wed 13 12:47
MTE4.2
Meet The Expert 4
Fighting liver fat
Oxford, UK
Anh Tran
Worcester Park, United Kingdom
Mon 11 13:35
OP2.3
Oral Posters 2 - Thyroid
Sustained improvements in monitoring and biochemical control of hypothyroidism in primary care with the use of an electronic protocol at two year follow up
Worcester Park, United Kingdom
Adam Truelove
Cambridge, United Kingdom
Tue 12 14:15
OP4.2
Oral Posters 4 - Bone and Calcium
Identification of novel pathogenic variants and phenotypic features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly defined inactivating PTH/PTHrP signalling disorders (iPPSD) classification system
Cambridge, United Kingdom
Dr Mark Turner
Coventry, UK
Mon 11 15:35
OC1.3
Oral Communications 1 - Metabolism and Obesity
Metabolic and functional effects of fatty acid overload on in vitro tissue engineered skeletal muscle.
Coventry, UK
Professor Jeremy Turner
Norwich, United Kingdom
Tue 12 15:45
NS2.3
Nurses' session 2: Management of Hyper & Hypocalcaemia
Patient management of hypocalcaemia & the patient perspective
Norwich, United Kingdom
Bijay Vaidya
Exeter
Tue 12 11:05
NS1.1
Nurses' session 1: NICE & T3
T3 replacement – What does the evidence suggest?
Exeter
Hugo Vankelecom
Leuven, Belgium
Mon 11 11:35
BPW1.2
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In vitro models of endocrinology: organoids from pituitary and endometrium
Leuven, Belgium
Joseph Verbalis
Georgetown University, USA
Mon 11 17:25
IN1.2
Innovation Session 1: Advances in understanding skeletal disease
Hyponatremia and osteoporosis
Georgetown University, USA
Jenny Visser
Rotterdam, The Netherlands
Tue 12 11:05
S2.1
Symposium 2: New insights into PCOS
Fetal antecedents of PCOS is there a role of AMH?
Rotterdam, The Netherlands
Margaritis Voliotis
Exeter, United Kingdom
Mon 11 12:05
BPW1.3
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In silico models of endocrinology: mathematical modelling of endocrine systems
Exeter, United Kingdom
Brian Walker
Edinburgh, UK
Mon 11 14:00
PL1
Plenary 1:Clinical Endocrinology Trust Lecture
Controlling cortisol in cardiometabolic disease
Edinburgh, UK
Dr Jennifer Walsh
Sheffield
Wed 13 12:25
MTE6
Meet The Expert 6
What have we learned from HR-pQCT?
Sheffield
Professor John Wass
Oxford, United Kingdom
Wed 13 15:35
ROE1.2
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
GIRFT Getting it Right First Time in endocrinology
Oxford, United Kingdom
Michael Whyte
St Louis, USA
Tue 12 08:30
PL4
Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
How is alkaline phosphatase essential for bone? The Transatlantic stories
St Louis, USA
Professor John Wilding
Liverpool, United Kingdom
Mon 11 17:25
IN3.2
Innovation Session 3: NIHR Pathways to clinical impact
Health Care Professionals, Industry and the NHS: delivering innovation
Liverpool, United Kingdom
Mon 11 18:40
D1.1
Debate: Nature vs Nurture
AGAINST - This house believes nature not nurture determines our bodyweight
Liverpool, United Kingdom
Tue 12 12:05
S1.3
Symposium 1: Gut hormones physiology pathology and pharamcology
Therapeutic landscape
Liverpool, United Kingdom
Xilin Wu
London, United Kingdom
Tue 12 15:45
OC5.5
Oral Communications 5 - Adrenal and Cardiovascular
Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells
London, United Kingdom
Lisa Yang
London, United Kingdom
Tue 12 16:00
OC6.6
Oral Communications 6 - Reproductive Endocrinology and Biology
Kisspeptin Enhances the Brain Processing of Attraction in Men
London, United Kingdom
Professor Giles Yeo
Cambridge, UK
Tue 12 17:57
ECS1.5
Early Careers Symposium: Engaging with the public
Endocrinology in the public eye
Cambridge, UK
Dr Phillip Yeoh
London, UK
Tue 12 14:45
NS2.1
Nurses' session 2: Management of Hyper & Hypocalcaemia
Aetiology of hyper and hypocalcaemia
London, UK
Dr Nicola Zammitt
Edinburgh, UK
Wed 13 09:50
SK1.2
Clincal Skills: Being a consultant - How to get the job and keep it
How to approach your first job plan - Get it right first time/How to get the job you want
Edinburgh, UK
Zhiyong Zou
Manchester, United Kingdom
Tue 12 15:45
OC6.5
Oral Communications 6 - Reproductive Endocrinology and Biology
Placental expression of estrogen related receptor γ (ERRγ) is hypoxia-sensitive and is altered in pregnancies complicated by fetal growth restriction
Manchester, United Kingdom
Mon 11 10:20
WIN1
What Is New
What is New in Basic Endocrinology Research
Birmingham, UK
Mon 11 10:35
WIN2
What Is New
What is New in Clinical Endocrinology Research
Sheffield, UK
Mon 11 11:05
CMW1.1
Clinical Management Workshop 1: Salt & Water
Management of hyponatraemia
Manchester, United Kingdom
Mon 11 11:35
CMW1.2
Clinical Management Workshop 1: Salt & Water
Diabetes Insipidus - management challenges and pitfalls
Bantry, Ireland
Mon 11 12:05
CMW1.3
Clinical Management Workshop 1: Salt & Water
Co-peptin- a new player in the diagnosis of salt and water balance
Basel, Switzerland
Mon 11 11:05
BPW1.1
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In vivo models of endocrinology: new zebrafish models
Padua, Italy
Mon 11 11:35
BPW1.2
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In vitro models of endocrinology: organoids from pituitary and endometrium
Leuven, Belgium
Mon 11 12:05
BPW1.3
Basic Physiology Workshop: Modelling endocrinology in vitro, in vivo & in silico
In silico models of endocrinology: mathematical modelling of endocrine systems
Exeter, United Kingdom
Wed 13 15:15
CMW2.1
Clinical Management Workshop 2: Hyperparathyroidism
Management of primary hyperparathyroidism in pregnancy
Edinburgh, United Kingdom
Wed 13 15:45
CMW2.2
Clinical Management Workshop 2: Hyperparathyroidism
Genetic testing in hyperparathyroidism across the ages- who to test and why
Cambridge, United Kingdom
Wed 13 16:15
CMW2.3
Clinical Management Workshop 2: Hyperparathyroidism
Challenges in recurrent hyperparathyroidism
Birmingham, United Kingdom
Wed 13 15:15
BPW2.1
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
In vivo imaging of endocrine cell networks
Montpellier, France
Wed 13 15:45
BPW2.2
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
Spatial programming of GPCR signalling
London, United Kingdom
Wed 13 16:15
BPW2.3
Basic Physiology Workshop: Imaging endocrinology from networks to organelles
High content imaging for monitoring signalling dynamics in single cells
Newcastle-Upon-Tyne, United Kingdom
Mon 11 12:50
OP1.1
Oral Posters 1 - Adrenal and Cardiovascular
Betamethasone/GR ChIP-Seq analysis defines a discrete set of canonical GR homodimer binding sites in primary fetal rat lung mesenchymal fibroblasts
Melbourne, Australia
Mon 11 12:55
OP1.2
Oral Posters 1 - Adrenal and Cardiovascular
ABSTRACT WITHDRAWN
Mon 11 13:00
OP1.3
Oral Posters 1 - Adrenal and Cardiovascular
Combining 11C-Metomidate PET/CT and 18F-FDG PET/CT – a new approach to phenotyping indeterminate adrenal lesions
Cambridge, UK
Mon 11 13:05
OP1.4
Oral Posters 1 - Adrenal and Cardiovascular
Global phosphoproteomics links rapidly induced cytoplasmic signals to transcriptional control
Leeds, United Kingdom
Mon 11 13:25
OP2.1
Oral Posters 2 - Thyroid
Day case radioiodine for remnant ablation in differentiated thyroid cancer patients is safe and helps reduce bed pressures in a busy tertiary centre hospital
London, UK
Mon 11 13:30
OP2.2
Oral Posters 2 - Thyroid
The SH2B3 tryptophan 262 variant is associated with Graves’ disease and Addison’s disease
Newcastle upon Tyne, United Kingdom
Mon 11 13:35
OP2.3
Oral Posters 2 - Thyroid
Sustained improvements in monitoring and biochemical control of hypothyroidism in primary care with the use of an electronic protocol at two year follow up
Worcester Park, United Kingdom
Mon 11 13:40
OP2.4
Oral Posters 2 - Thyroid
The proto-oncogene PBF mediates Src modulation of radioiodine uptake
Birmingham, United Kingdom
Mon 11 15:05
OC1.1
Oral Communications 1 - Metabolism and Obesity
Intracrine activation of 11-oxygenated androgens by AKR1C3 modulates lipid metabolism in human female adipose tissue
Birmingham, United Kingdom
Mon 11 15:20
OC1.2
Oral Communications 1 - Metabolism and Obesity
Hepatic de novo lipogenesis is suppressed and fat oxidation is increased by omega-3 fatty acids at the expense of glucose metabolism
Oxford, UK
Mon 11 15:35
OC1.3
Oral Communications 1 - Metabolism and Obesity
Metabolic and functional effects of fatty acid overload on in vitro tissue engineered skeletal muscle.
Coventry, UK
Mon 11 15:50
OC1.4
Oral Communications 1 - Metabolism and Obesity
5β-reductase (AKR1D1) is downregulated in patients with non-alcoholic fatty liver disease and protects against hepatocellular carcinoma cell proliferation in vitro.
Oxford, United Kingdom
Mon 11 16:05
OC1.5
Oral Communications 1 - Metabolism and Obesity
Prolyl-hydroxylase 3 maintains β-cell glucose-sensing under metabolic stress
Birmingham, United Kingdom
Mon 11 16:20
OC1.6
Oral Communications 1 - Metabolism and Obesity
Metabolic surgery reduces kidney SGLT2 expression in mice
London, United Kingdom
Mon 11 15:05
OC2.1
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Differential effects of subcutaneous pulsatile versus oral hydrocortisone replacement therapy on fMRI resting state and task based emotional processing in Patients with Primary Adrenal insufficiency
Bristol, United Kingdom
Mon 11 15:20
OC2.2
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Investigating the role of AIP in pituitary tumourigenesis
London, UK
Mon 11 15:35
OC2.3
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
ErbB receptor signalling in MCF7 breast cancer cells: an information theoretic approach
Bristol Medical School, United Kingdom
Mon 11 15:50
OC2.4
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Investigating the role of vagal Y2R in PYY3-36-mediated appetite suppression
London, United Kingdom
Mon 11 16:05
OC2.5
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Efnb2 controls pituitary gland development by regulating proliferation of the pituitary stem/progenitor cells and EMT within the pituitary stem cell niche.
London, United Kingdom
Mon 11 16:20
OC2.6
Oral Communications 2 - Neuroendocrinology, Pituitary and Neoplasia
Post-operative copeptin analysis as a predictor of diabetes insipidus after pituitary surgery
Oxford, United Kingdom
Mon 11 15:05
OC3.1
Oral Communications 3 - Bone and Calcium
A mouse model generated by CRISPR-Cas9 with a frameshift mutation in the nuclear factor 1/X (NFIX) gene has phenotypic features reported in Marshall-Smith Syndrome (MSS) patients
Oxford, UK
Mon 11 15:20
OC3.2
Oral Communications 3 - Bone and Calcium
Hypophosphatasia in adulthood - are patients really “unaffected”
Glasgow, United Kingdom
Mon 11 15:35
OC3.3
Oral Communications 3 - Bone and Calcium
Generation of a long acting parathyroid hormone hybrid analogue through fusion to a binding protein
Sheffield, United Kingdom
Mon 11 15:50
OC3.4
Oral Communications 3 - Bone and Calcium
Characterisation of rare GNA11 variants reveals 8 novel residues important for signalling by the calcium-sensing receptor: Relevance for FHH and ADH
Oxford, UK
Mon 11 16:05
OC3.5
Oral Communications 3 - Bone and Calcium
Mutational analysis of a patient with familial hypocalciuric hypercalcaemia identifies a novel p.Ser182Cys mutation, which is predicted to disrupt the calcium sensing receptor (CaSR) extracellular domain
Oxford, United Kingdom
Mon 11 16:20
OC3.6
Oral Communications 3 - Bone and Calcium
The role of biased calcium-sensing receptor signalling in urinary calcium excretion and kidney stone disease
Oxford, UK
Tue 12 09:35
EC1.1
Early Careers and Plenary Orals
Early Career Prize lecture Basic Science
London, United Kingdom
Tue 12 09:55
EC1.2
Early Careers and Plenary Orals
Early Career Prize lecture Translational
Leeds, United Kingdom)
Tue 12 10:15
EC1.3
Early Careers and Plenary Orals
Urine steroid metabolome analysis allows for metabolic risk stratification in 1309 prospectively recruited patients with benign adrenal tumours and different degrees of cortisol excess
Birmingham, UK
Tue 12 10:25
EC1.4
Early Careers and Plenary Orals
CET Best Abstract Basic
Oxford, United Kingdom
Tue 12 13:35
OP3.1
Oral Posters 3 - Metabolism and Obesity
Intermittent cold exposure ameliorates fatty liver disease
London, United Kingdom
Tue 12 13:40
OP3.2
Oral Posters 3 - Metabolism and Obesity
Intestinal injury and evidence of increased gut permeability in female AKR1D1 knockout mice
Oxford, United Kingdom
Tue 12 13:45
OP3.3
Oral Posters 3 - Metabolism and Obesity
The Impact of Subcutaneous Infusions of three Anorexigenic Gut Hormones Glucagon-like Peptide-1, Oxyntomodulin and Peptide YY (GOP) on the Psychological Health of Obese Diabetic Patients.
London, United Kingdom
Tue 12 13:50
OP3.4
Oral Posters 3 - Metabolism and Obesity
Mice with a gain-of function Gα11 mutation have autosomal dominant hypocalcaemia, but not impaired glucose metabolism.
Oxford, UK
Tue 12 14:10
OP4.1
Oral Posters 4 - Bone and Calcium
Oral calcium loading test can predict the progression of hypercalcaemic primary hyperparathyroidism in patients with normocalcaemic hyperparathyroidism
London, United Kingdom
Tue 12 14:15
OP4.2
Oral Posters 4 - Bone and Calcium
Identification of novel pathogenic variants and phenotypic features in patients with pseudohypoparathyroidism and acrodysostosis, subtypes of the newly defined inactivating PTH/PTHrP signalling disorders (iPPSD) classification system
Cambridge, United Kingdom
Tue 12 14:20
OP4.3
Oral Posters 4 - Bone and Calcium
Mendelian randomization and machine learning to assess the causal association of Type 2 Diabetes with osteoporosis and fragility fractures
Hull, United Kingdom
Tue 12 14:25
OP4.4
Oral Posters 4 - Bone and Calcium
The associations between body fat distribution and bone mineral density in the Oxford Biobank: a cross sectional study
Oxford, United Kingdom
Tue 12 14:45
OC4.1
Oral Communications 4 - Thyroid
A high-throughput yellow fluorescent protein (YFP) cell-based screen identifies autophagy modulators to increase the effectiveness of radioiodine therapy
Birmingham, UK
Tue 12 15:00
OC4.2
Oral Communications 4 - Thyroid
Reduced Length of Hospital Stay with the use of recombinant TSH compared to Thyroid Hormone Withdrawal –A two centre retrospective study
Aberdeen, United Kingdom
Tue 12 15:15
OC4.3
Oral Communications 4 - Thyroid
The disturbed thyroid gland homeostasis in conditions of subacute exposure to thyroid-disrupting chemicals: experimental study in Wistar rats
Belgrade, Serbia
Tue 12 15:30
OC4.4
Oral Communications 4 - Thyroid
Development of auto-immune thyroid dysfunction in multiple sclerosis patients receiving Alemtuzumab is associated with improved response to treatment
London, United Kingdom
Tue 12 15:45
OC4.5
Oral Communications 4 - Thyroid
The prevalence of thyroid dysfunction and autoimmunity in women with history of miscarriage or subfertility across the United Kingdom
Birmingham, United Kingdom
Tue 12 16:00
OC4.6
Oral Communications 4 - Thyroid
Driver events in thyroid cancer recurrence
Birmingham, United Kingdom
Tue 12 14:45
OC5.1
Oral Communications 5 - Adrenal and Cardiovascular
Central role for corticosteroid-binding globulin in rat HPA axis sexual dimorphism
Vancouver, Canada
Tue 12 15:00
OC5.2
Oral Communications 5 - Adrenal and Cardiovascular
Subclinical alpha-1 antitrypsin deficiency is associated with increased free cortisol fraction in plasma
Edinburgh, United Kingdom
Tue 12 15:15
OC5.3
Oral Communications 5 - Adrenal and Cardiovascular
Common variants in the gene encoding corticosteroid binding globulin influence cortisol-responsive gene networks in human adipose tissue
Edinburgh, United Kingdom
Tue 12 15:30
OC5.4
Oral Communications 5 - Adrenal and Cardiovascular
Pre-receptor metabolism and signalling of glucocorticoids between macrophages and fibroblasts
Birmingham, United Kingdom
Tue 12 15:45
OC5.5
Oral Communications 5 - Adrenal and Cardiovascular
Somatic transmembrane domain mutations of a cell adhesion molecule, CADM1, cause primary aldosteronism by preventing gap junction communication between adrenocortical cells
London, United Kingdom
Tue 12 16:00
OC5.6
Oral Communications 5 - Adrenal and Cardiovascular
SLC35F1, a potential marker for aldosterone producing cell clusters
London, United Kingdom
Tue 12 14:45
OC6.1
Oral Communications 6 - Reproductive Endocrinology and Biology
Effect of MVT-602, a potent kisspeptin receptor agonist, on LH levels in healthy pre-menopausal women undergoing a minimal controlled ovarian stimulation protocol
London, United Kingdom
Tue 12 15:00
OC6.2
Oral Communications 6 - Reproductive Endocrinology and Biology
Differential follicle stimulating hormone glycosylation modulates follicle growth and survival rates
London, UK
Tue 12 15:15
OC6.3
Oral Communications 6 - Reproductive Endocrinology and Biology
Investigating the impact of altered maternal extracellular vesicle miRNAs on placental function in women with gestational diabetes complicated by large for gestational age infants
Leeds, United Kingdom
Tue 12 15:30
OC6.4
Oral Communications 6 - Reproductive Endocrinology and Biology
Kallmann syndrome-associated WDR11 regulates primordial germ cell development
London, United Kingdom
Tue 12 15:45
OC6.5
Oral Communications 6 - Reproductive Endocrinology and Biology
Placental expression of estrogen related receptor γ (ERRγ) is hypoxia-sensitive and is altered in pregnancies complicated by fetal growth restriction
Manchester, United Kingdom
Tue 12 16:00
OC6.6
Oral Communications 6 - Reproductive Endocrinology and Biology
Kisspeptin Enhances the Brain Processing of Attraction in Men
London, United Kingdom
Wed 13 13:20
OP5.1
Oral Posters 5 - Reproductive Endocrinology and Biology
Hypothalamic-pituitary-gonadal (HPG) axis suppression during basic military training in women despite increased adiposity and insulin resistance
Edinburgh, United Kingdom
Wed 13 13:25
OP5.2
Oral Posters 5 - Reproductive Endocrinology and Biology
Profiling the expression and function of the truncated oestrogen receptor isoform ER46 in human endometrium
Edinburgh, United Kingdom
Wed 13 13:30
OP5.3
Oral Posters 5 - Reproductive Endocrinology and Biology
Stress is implicated in programming metabolic disorders in the offspring of fructose-induced diabetic rats
Lagos, Nigeria
Wed 13 13:35
OP5.4
Oral Posters 5 - Reproductive Endocrinology and Biology
Kisspeptin as a novel biomarker for pregnancy complications
London, United Kingdom
Wed 13 13:55
OC6.1
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Extended TSS (guided by 11C-methionine PET + MRI (Met-PET/MRCR)) can be an effective treatment option for patients with persistent acromegaly due to previously deemed unresectable lateral disease
Cambridge, United Kingdom
Wed 13 14:00
OC6.2
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Transcriptomic analyses reveal deregulation of focal adhesion pathway in Aip KO mice and AIP mutation positive human tumours
London, United Kingdom
Wed 13 14:05
OP6.3
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
JQ1 treatment significantly reduces POMC expression and ACTH secretion from the corticotrophinoma cell line, AtT20
Oxford, United Kingdom
Wed 13 14:10
OP6.4
Oral Posters 6 - Neuroendocrinology, Pituitary and Neoplasia
Urine steroid metabolomics as a novel diagnostic tool for recurrent adrenocortical carcinoma detection
Birmingham, United Kingdom
Tue 12 12:40
MTE1
Meet The Expert 1
Thyroid disease after immune reconstitution
Dublin, Ireland
Tue 12 12:40
MTE2
Meet The Expert 2
When should I consider functional imaging in adrenocortical disease?

Unknown speaker

Cambridge, UK
Tue 12 12:40
MTE3
Meet The Expert 3
Update on DSD genetics
London, United Kingdom
Wed 13 12:25
MTE4.1
Meet The Expert 4
Fighting liver fat
Oxford, United Kingdom
Wed 13 12:47
MTE4.2
Meet The Expert 4
Fighting liver fat
Oxford, UK
Wed 13 12:25
MTE5
Meet The Expert 5
Novel Epigenetic inhibitors
Oxford, United Kingdom
Wed 13 12:25
MTE6
Meet The Expert 6
What have we learned from HR-pQCT?
Sheffield
Mon 11 14:00
PL1
Plenary 1:Clinical Endocrinology Trust Lecture
Controlling cortisol in cardiometabolic disease
Edinburgh, UK
Mon 11 14:30
PL2
Plenary 2: Society for Endocrinology Starling Medal Lecture
From its origins to the modern metabolic network
London, United Kingdom
Mon 11 18:10
PL3
Plenary 3: Society for Endocrinology Dale Medal Lecture
From Carney complex to gigantism and Cushing disease: an insight in the genetics of pituitary tumors
Greece
Tue 12 08:30
PL4
Plenary 4: Society for Endocrinology Transatlantic Medal Lecture
How is alkaline phosphatase essential for bone? The Transatlantic stories
St Louis, USA
Tue 12 18:20
PL6
Plenary 6: Society for Endocrinology European Medal Lecture
Mechanisms and consequences of endocrine autonomy – lessons learned from the adrenal cortex
Zürich, Switzerland
Wed 13 08:30
PL7
Plenary 7: British Thyroid Association Pitt-Rivers Lecture
Thyroid cancer genomics, differentiation state and response to radioiodine
New York, USA)
Wed 13 09:00
PL8
Plenary 8: CET Visiting Professor Lecture
Cushing’s syndrome as a model of endocrine tumorigenesis
Paris, France
Wed 13 16:50
PL9
Plenary 9: Society for Endocrinology Medal Lecture
Sex steroids and the endometrium: dynamics and disorders
Edinburgh, United Kingdom
Wed 13 17:30
PL10
Plenary 10: Society for Endocrinology Jubilee Medal Lecture
Pituitary cells alive: hormone genes pulsing on and off
Manchester, United Kingdom
Mon 11 12:35
LUNCH, EXHIBITION, SATELLITES & POSTERS
Auditorium 1
Mon 11 16:35
TEA & COFFEE
Auditorium 1
Mon 11 19:25
Presidential Welcome Reception
Tue 12 10:35
TEA & COFFEE
Auditorium 1
Tue 12 13:25
LUNCH, EXHIBITION & POSTERS
Auditorium 1
Tue 12 16:15
TEA & COFFEE
Auditorium 1
Wed 13 10:20
TEA & COFFEE
Auditorium 1
Wed 13 13:10
LUNCH, EXHIBITION & POSTERS
Auditorium 1
Tue 12 11:05
NS1.1
Nurses' session 1: NICE & T3
T3 replacement – What does the evidence suggest?
Exeter
Tue 12 11:35
NS1.2
Nurses' session 1: NICE & T3
The health care professional & patient consultation - Informed decision making
Exeter, UK
Tue 12 12:05
NS1.3
Nurses' session 1: NICE & T3
A Beginners Guide: setting up a Nurse-Led Thyroid Clinic
Portsmouth, United Kingdom
Tue 12 14:45
NS2.1
Nurses' session 2: Management of Hyper & Hypocalcaemia
Aetiology of hyper and hypocalcaemia
London, UK
Tue 12 15:15
NS2.2
Nurses' session 2: Management of Hyper & Hypocalcaemia
Patient management of hypercalcaemia & when should the surgeon intervene?
Birmingham, United Kingdom
Tue 12 15:45
NS2.3
Nurses' session 2: Management of Hyper & Hypocalcaemia
Patient management of hypocalcaemia & the patient perspective
Norwich, United Kingdom
Mon 11 09:00
REGISTRATION
Mon 11 11:05
HDI1.1
How do I…1
Management of osteoporosis in children and adolescents
London, United Kingdom
Mon 11 11:20
HDI1.2
How do I…1
How do I manage an incidental finding of a thyroid nodule
Birmingham, UK
Mon 11 11:35
HDI1.3
How do I…1
How do I decide which patients with gynaecomastia need more detailed evaluation?
London, United Kingdom
Mon 11 11:50
HDI1.4
How do I…1
How do I manage hair loss and hair growth in PCOS?
Cardiff, United Kingdom
Mon 11 12:05
HDI1.5
How do I…1
How do I induce spermatogenesis?
London, United Kingdom
Mon 11 12:20
HDI1.6
How do I…1
How do I choose between weight loss interventions?
Birmingham, UK
Mon 11 17:05
IN1.1
Innovation Session 1: Advances in understanding skeletal disease
Identifying new skeletal disease
Helsinki, Finland
Mon 11 17:25
IN1.2
Innovation Session 1: Advances in understanding skeletal disease
Hyponatremia and osteoporosis
Georgetown University, USA
Mon 11 17:45
IN1.3
Innovation Session 1: Advances in understanding skeletal disease
Bone fragility in patients with chronic kidney diseases
Paris, France
Mon 11 17:05
IN2.1
Innovation Session 2: Big data in space and time
Single cell RNA-seq of endocrine organs
London, UK
Mon 11 17:35
IN2.2
Innovation Session 2: Big data in space and time
Data Science Approaches to GPCRs and Nuclear Receptors
(Cambridge, United Kingdom)
Mon 11 18:40
D1.1
Debate: Nature vs Nurture
AGAINST - This house believes nature not nurture determines our bodyweight
Liverpool, United Kingdom
Mon 11 18:40
D1.2
Debate: Nature vs Nurture
FOR - This house believes nature not nurture determines our bodyweight
Cambridge, UK
Tue 12 07:30
REGISTRATION
Tue 12 16:45
HDI2.1
How do I…2
How do I diagnose cyclical Cushing's
Sheffield, UK
Tue 12 17:00
HDI2.2
How do I…2
How should I manage non-standard thyroid hormone replacement
Cardiff, UK
Tue 12 17:15
HDI2.3
How do I…2
When and how should I start screening for MEN1 in children
Bristol, United Kingdom
Tue 12 17:30
HDI2.4
How do I…2
How do I decide when to initiate dopamine agonist withdrawal
Birmingham, UK
Tue 12 17:45
HDI2.5
How do I…2
How do I… manage therapeutic glucocorticoid withdrawal

Unknown speaker

Manchester, UK
Tue 12 18:00
HDI2.6
How do I…2
How do I manage withdrawal of denosumab
Dublin, Ireland
Tue 12 16:45
SE1.1
Senior Endocrinologists' Session
What happened to the adrenal X-zone?
Ayr, United Kingdom
Tue 12 17:15
SE1.2
Senior Endocrinologists' Session
Is the estrogenic component of Premarin all bad?
Virginia, USA
Tue 12 17:45
SE1.3
Senior Endocrinologists' Session
Potential benefits of better vitamin D status for non-bony disorders?
London, United Kingdom
Tue 12 18:50
Society for Endocrinology AGM - members only
Auditorium 2
Wed 13 07:30
REGISTRATION
Wed 13 09:35
SK1.1
Clincal Skills: Being a consultant - How to get the job and keep it
How to get the consultant post you want
Oxford, UK
Wed 13 09:50
SK1.2
Clincal Skills: Being a consultant - How to get the job and keep it
How to approach your first job plan - Get it right first time/How to get the job you want
Edinburgh, UK
Wed 13 10:05
SK1.3
Clincal Skills: Being a consultant - How to get the job and keep it
How do I set up a new service?
Cardiff, United Kingdom
Wed 13 09:35
SK2.1
Basic Skills: Introduction to teaching
Getting started in undergraduate teaching; what, when and how?
London, United Kingdom
Wed 13 09:57
SK2.2
Basic Skills: Introduction to teaching
Challenging students and difficult supervisors; how to supervise students effectively when things go wrong. 
London, United Kingdom
Wed 13 09:35
SK3.1
Teaching Skills: Innovations in teaching
New approaches to effective teaching
Wed 13 09:57
SK3.2
Teaching Skills: Innovations in teaching
Innovative teaching exercise
Wed 13 14:25
Endocrine Network: Bone and Calcium
Meeting Room 14
Wed 13 14:25
Endocrine Network: Neuroendocrinology
Meeting Room 6
Wed 13 14:25
Endocrine Network: Endocrine Neoplasia Syndromes
Auditorium 2
Wed 13 14:25
Endocrine Network: Endocrine Consequences of Living with and Beyond Cancer
Meeting room 10
Wed 13 14:25
Endocrine Network: Thyroid
Syndicate 3 & 4
Wed 13 14:25
Endocrine Network: Metabolic and Obesity
Syndicate 1 & 2
Wed 13 14:25
Endocrine Network: Adrenal and Cardiovascular
Meeting room 9
Wed 13 14:25
Endocrine Network: Reproductive Endocrinology and Biology
Meeting Room 8
Wed 13 15:15
ROE1.1
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
National standards and the specialised endocrinology Clinical Reference Group
Birmingham, United Kingdom
Wed 13 15:35
ROE1.2
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
GIRFT Getting it Right First Time in endocrinology
Oxford, United Kingdom
Wed 13 15:55
ROE1.3
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
SfE Interdepartmental peer review
Exeter, UK
Wed 13 16:15
ROE1.4
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
The 2018 diabetes and endocrinology consultant workforce survey (SfE/ABCD/DUK)
Stevenage, United Kingdom
Wed 13 16:35
ROE1.5
Endocrinology in the UK: Workforce, Standards, and Quality Improvement
Q&A
Wed 13 17:20
Prizes and Awards
Auditorium 2
Tue 12 11:05
S1.1
Symposium 1: Gut hormones physiology pathology and pharamcology
Physiology and pharmacology of gut hormones
Cambridge, United Kingdom
Tue 12 11:35
S1.2
Symposium 1: Gut hormones physiology pathology and pharamcology
Combination of gut hormone therapy
London, United Kingdom
Tue 12 12:05
S1.3
Symposium 1: Gut hormones physiology pathology and pharamcology
Therapeutic landscape
Liverpool, United Kingdom
Tue 12 11:05
S2.1
Symposium 2: New insights into PCOS
Fetal antecedents of PCOS is there a role of AMH?
Rotterdam, The Netherlands
Tue 12 11:35
S2.2
Symposium 2: New insights into PCOS
PCOS, obesity and energy balance
Edinburgh, UK
Tue 12 12:05
S2.3
Symposium 2: New insights into PCOS
Origins of obesity in women with PCOS
Oulu, Finland
Tue 12 11:05
S3.1
Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
Advances in FGF23 Signalling
New Haven, USA)
Tue 12 11:35
S3.2
Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
Phosphate Sensing
Nantes, France
Tue 12 12:05
S3.3
Symposium 3: Phosphate homeostasis physiology pathology and pharmacology
FGF23-Related Hypophosphatemic Diseases: Prospect for New Treatment
Tokushima, Japan
Tue 12 16:45
ECS1.1
Early Careers Symposium: Engaging with the public
How your Society can help you engage the public
London, UK
Tue 12 17:03
ECS1.2
Early Careers Symposium: Engaging with the public
Making the best of what you’re given – public engagement grants
Leeds, United Kingdom
Tue 12 17:21
ECS1.3
Early Careers Symposium: Engaging with the public
How to reach out across social media
London, UK
Tue 12 17:39
ECS1.4
Early Careers Symposium: Engaging with the public
Meaningful engagement with patients: The importance of recognising common humanity in patients is key to improving relationships’
Oxford, UK
Tue 12 17:57
ECS1.5
Early Careers Symposium: Engaging with the public
Endocrinology in the public eye
Cambridge, UK
Wed 13 10:50
S4.1
Symposium 4: Thyroid hormone a key regulator in inflammation?
Thyroid hormone inhibits lung fibrosis 
Chicago, USA
Wed 13 11:20
S4.2
Symposium 4: Thyroid hormone a key regulator in inflammation?
Thyroid hormone regulation of Inflammation 
Amsterdam, The Netherlands
Wed 13 11:50
S4.3
Symposium 4: Thyroid hormone a key regulator in inflammation?
TED novel agents how they work and how to use them CIRTED MINGO papers
Oregon Health & Science University, USA
Wed 13 10:50
S5.1
Symposium 5: Stress – The rhythm of life
The interplay between stress, biological clocks and metabolic function
Lübeck, Germany
Wed 13 11:20
S5.2
Symposium 5: Stress – The rhythm of life
Dynamic of Adrenal in health and disease
Bristol, United Kingdom
Wed 13 11:50
S5.3
Symposium 5: Stress – The rhythm of life
The interplay between sleep and the endocrine system
Birmingham, UK
Wed 13 10:50
S6.1
Symposium 6: New horizons in neuro-endocrine disease
Preclinical drug studies for MEN1 NETs
Hadassah, Israel
Wed 13 11:20
S6.2
Symposium 6: New horizons in neuro-endocrine disease
Using genetics to inform on pharmalogical targeting of NETs
London, United Kingdom
Wed 13 11:50
S6.3
Symposium 6: New horizons in neuro-endocrine disease
Molecular endocrine imaging in occult de novo or recurrent pituitary disease

Unknown speaker

Cambridge, UK
Mon 11 11:00
One Minute Silence
Mon 11 17:05
IN3.1
Innovation Session 3: NIHR Pathways to clinical impact
From basic science to life changing therapies
London, UK
Mon 11 17:25
IN3.2
Innovation Session 3: NIHR Pathways to clinical impact
Health Care Professionals, Industry and the NHS: delivering innovation
Liverpool, United Kingdom
Mon 11 17:45
IN3.3
Innovation Session 3: NIHR Pathways to clinical impact
Championing Rare Disease Research

Unknown speaker

London, UK
Tue 12 09:00
PL5
Plenary 5: Society for Endocrinology International Medal Lecture
The Melanocortin Microcircuitry and its Role in Energy Homeostasis
Ann Arbor, USA

0 result(s) found.